A study to assess the safety and immune response of quadrivalent seasonal influenza vaccine (Fluarix Tetra) in participants aged 65 years and older in India

Trial Identifier: 218702
Sponsor: GlaxoSmithKline
Start Date: December 2023
Primary Completion Date: February 2024
Study Completion Date: February 2024
Condition: Influenza Immunisation

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description

Trial Locations

Country Location
India Belagavi, India, 590010
India Kattankulathur, India, 603211
India Nashik, India, 422002
India Nashik, India, 422003
India Varanasi, India, 221010
India Vishakha Patnam, India, 530002